AMD is putting its heart and soul into helping Absci develop new AI technology for healthcare!

 AMD is putting its heart and soul into helping Absci develop new AI technology for healthcare!

AMD, a U.S. semiconductor giant, is investing $20 million in Absci, a drug discovery company. They're teaming up to bring AMD's advanced AI chips to the healthcare industry. This investment, made using a private equity approach, marks AMD's first step into the life sciences sector. AMD plans to optimize Absci's AI drug discovery efforts by providing high-performance Instinct gas pedals and ROCm software.Absci, which currently uses more than 470 AI chips, mostly from its competitor Nvidia, will gradually start using AMD's. Sean McLean, Absci's founder and CEO, said the partnership will significantly enhance Absci's biological modeling capabilities and accelerate the development of antibody therapeutics.


Movement Labs is about to close a $100 million funding round at a valuation of $3 billion, which is fantastic news for the company and for the new era of Ether scaling.Movement Labs, a team focused on the development of the Layer-2 blockchain for Ether, recently announced the exciting news that it is about to close a $100 million Series B funding round at a valuation of $3 billion. This exciting round, co-led by CoinFund and Brevan Howard's Nova Fund, is expected to close by the end of January. This funding will provide Movement Labs with the financial support it needs to continue growing. This will follow the company's very successful $38 million Series A round raised in April 2024.

Comments

Popular posts from this blog

The iPhone suddenly dropped in price, and the 14 Pro dropped by up to 800 yuan! Sales in Greater China have fallen sharply, is Apple in a hurry?

WordPress.org has launched a high-performance translation plug-in to solve performance problems caused by translation

120x zoom! Mi 13 Ultra revealed to be launched in April